Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triiodothyronine Supplementation in Septic Shock with ESS
NCT05270798Phase 2Completed
- Sponsor
- Cantonal Hospital Zenica
- Start
- May 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liothyronine in euthyroid sick syndrome (NTIS), sponsored by Cantonal Hospital Zenica. Started May 2022; status: completed.
02
Drugs
liothyronine
03
Conditions
euthyroid sick syndrome (NTIS)
Beyond the preview
Go deeper on NCT05270798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05270798.